Developing Next Generation, Continuous Glucose Monitoring Systems for People with Diabetes

GlySens Incorporated is a privately held corporation devoted to developing the world’s first truly long term continuous glucose monitoring system. Our goal: to enable easy, unobtrusive, worry-free diabetes control that empowers users by providing the information they need to optimize care, while freeing them to live life on their own terms.

Company Strengths

  • Solid scientific foundation and recognition; leveraging 30+ years of best-in-class university research
  • Numerous peer-reviewed awards directly to GlySens from NIH, DOD, JDRF, etc. validate the Company’s science
  • Scientifically rigorous engineering development program; strong in-house R&D capabilities
  • Strong IP position with issued patents and additional patents pending
  • Highly capital efficient operation – outstanding record of achievement in peer-reviewed grants and contracts
  • GlySens academic partner, the University of California at San Diego (UCSD), provides unique collaboration strengths unavailable through any other source
“…If the device works well in people, it could revolutionize the way most diabetics manage their disease, several doctors said. With diabetes affecting about 24 million Americans, the monitor has the potential to become a blockbuster product.  The GlySens monitor also exemplifies the convergence of medicine and cell phone technology, a burgeoning trend that promises to transform the way health care is delivered in the United States and around the world.”
Keith Darcé, Journalist, S.D. company hopes monitor will revolutionize diabetes care, San Diego Union Tribune, 29 July 2010